Correspondence 0000950170-23-012709 from Arcadia Biosciences, Inc. (RKDA) (CIK 0001469443) (RKDA)
Arcadia Biosciences, Inc. (RKDA) (CIK 0001469443)
Date: April 13, 2023 · CIK: 0001469443 · Accession: 0000950170-23-012709
AI Filing Summary & Sentiment
File numbers found in text: 333-271082
Letter
VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services Attention: Conlon Danberg Re: Arcadia Biosciences, Inc. Registration Statement on Form S-3 (No. 333-271082) Request for Acceleration
Dear Mr. Danberg:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Arcadia Biosciences, Inc. hereby requests that the effective date of its Registration Statement on Form S-3 (File No. 333-271082) be accelerated so that the same will become effective at 5:00 p.m., Eastern Time, on Monday, April 17, 2023, or as soon thereafter as practicable.
If you have any questions regarding this request or the Registration Statement, please call our counsel Jeff Pietsch of Weintraub Tobin, at (916) 558-6118.
Very truly yours,
Arcadia Biosciences, Inc.
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
Arcadia Biosciences, Inc.
5950 Sherry Lane, Suite 215
Dallas, TX 75225
April 13, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Attention: Conlon Danberg
Re: Arcadia Biosciences, Inc.
Registration Statement on Form S-3 (No. 333-271082)
Request for Acceleration
Dear Mr. Danberg:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Arcadia Biosciences, Inc. hereby requests that the effective date of its Registration Statement on Form S-3 (File No. 333-271082) be accelerated so that the same will become effective at 5:00 p.m., Eastern Time, on Monday, April 17, 2023, or as soon thereafter as practicable.
If you have any questions regarding this request or the Registration Statement, please call our counsel Jeff Pietsch of Weintraub Tobin, at (916) 558-6118.
Very truly yours,
Arcadia Biosciences, Inc.
By: /s/ Thomas J. Schaefer
Thomas J. Schaefer
Chief Financial Officer